Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China
· Delayed Price · Currency is CNY 3.040
+0.120 (4.11%)
Apr 29, 2026, 3:00 PM CST
SHA:603077 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 23,352 | 18,021 | 16,372 | 20,591 | 26,524 | 28,624 | Upgrade
|
| Market Cap Growth | 59.88% | 10.07% | -20.49% | -22.37% | -7.33% | 136.22% | Upgrade
|
| Enterprise Value | 25,690 | 20,375 | 17,861 | 19,320 | 24,994 | 28,461 | Upgrade
|
| Last Close Price | 2.92 | 2.26 | 2.04 | 2.34 | 2.96 | 3.30 | Upgrade
|
| PE Ratio | - | - | 520.33 | 16.05 | 6.97 | 9.48 | Upgrade
|
| Forward PE | - | 37.06 | 37.06 | 37.06 | 37.06 | 37.06 | Upgrade
|
| PS Ratio | 3.25 | 2.51 | 1.92 | 2.33 | 2.03 | 2.87 | Upgrade
|
| PB Ratio | 1.30 | 1.00 | 0.86 | 1.02 | 1.34 | 1.96 | Upgrade
|
| P/TBV Ratio | 1.76 | 1.36 | 1.14 | 1.33 | 1.75 | 2.76 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 15.53 | 19.58 | Upgrade
|
| P/OCF Ratio | 21.70 | 16.74 | 34.99 | 256.33 | 10.03 | 8.75 | Upgrade
|
| EV/Sales Ratio | 3.57 | 2.84 | 2.09 | 2.19 | 1.92 | 2.85 | Upgrade
|
| EV/EBITDA Ratio | 20.00 | 16.13 | 19.33 | 8.02 | 4.63 | 6.65 | Upgrade
|
| EV/EBIT Ratio | 96.58 | 76.60 | - | 13.59 | 5.57 | 7.80 | Upgrade
|
| EV/FCF Ratio | -140.63 | - | - | - | 14.63 | 19.47 | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.49 | 0.42 | 0.10 | 0.09 | 0.09 | Upgrade
|
| Debt / EBITDA Ratio | 6.28 | 6.78 | 8.61 | 0.81 | 0.34 | 0.32 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 1.06 | 0.94 | Upgrade
|
| Net Debt / Equity Ratio | 0.12 | 0.11 | 0.06 | -0.05 | -0.14 | -0.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.59 | 1.60 | 1.14 | -0.45 | -0.51 | -0.09 | Upgrade
|
| Net Debt / FCF Ratio | -82.05 | -11.03 | -1.63 | 1.46 | -1.62 | -0.27 | Upgrade
|
| Asset Turnover | 0.23 | 0.25 | 0.32 | 0.36 | 0.62 | 0.61 | Upgrade
|
| Inventory Turnover | 1.32 | 1.50 | 1.79 | 2.11 | 5.01 | 7.60 | Upgrade
|
| Quick Ratio | 2.44 | 2.04 | 1.69 | 1.40 | 1.92 | 1.10 | Upgrade
|
| Current Ratio | 3.85 | 3.18 | 2.61 | 2.69 | 2.60 | 1.49 | Upgrade
|
| Return on Equity (ROE) | -2.97% | -3.86% | -0.36% | 6.40% | 22.15% | 23.33% | Upgrade
|
| Return on Assets (ROA) | 0.90% | 0.57% | -0.12% | 3.65% | 13.34% | 13.97% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.09% | 1.33% | -0.26% | 6.55% | 24.44% | 23.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.70% | 1.10% | -0.20% | 6.80% | 22.00% | 24.70% | Upgrade
|
| Earnings Yield | -2.30% | -2.98% | 0.19% | 6.23% | 14.35% | 10.54% | Upgrade
|
| FCF Yield | -0.78% | -1.01% | -3.96% | -3.64% | 6.44% | 5.11% | Upgrade
|
| Dividend Yield | 0.68% | - | 0.98% | - | 1.52% | 0.46% | Upgrade
|
| Payout Ratio | - | - | 783.94% | 36.13% | 5.20% | 2.58% | Upgrade
|
| Buyback Yield / Dilution | 11.34% | -20.84% | 2.32% | -0.10% | -3.09% | 1.10% | Upgrade
|
| Total Shareholder Return | 12.02% | -20.84% | 3.30% | -0.10% | -1.57% | 1.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.